Juul’s new suit against US FDA seeks materials withheld in suspended MDO

Juul Labs is asking a judge to order the US Food and Drug Administration (FDA) to release information related to its now-vacated denial of the company’s premarket tobacco application (PMTA), calling the withholding of material “part of a troubling pattern of decreasing transparency at the agency”.

In a lawsuit filed 20th September, lawyers for Juul said they served the FDA with two requests for the “scientific disciplinary reviews” behind its decision to reject the PMTA and order all Juul products off the US market. The requests were made “less than a day” after the FDA issued its marketing denial order (MDO) to Juul on 23rd June.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization